Ortonne N - Search Results

1

Histopathological and immunophenotypical criteria for the diagnosis of Sézary syndrome in differentiation from other erythrodermic skin diseases: a European Organisation for Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Task Force Study of 97 cases.

Klemke CD, Booken N, Weiss C, Nicolay JP, Goerdt S, Felcht M, Géraud C, Kempf W, Assaf C, Ortonne N, Battistella M, Bagot M, Knobler R, Quaglino P, Arheiliger B, Santucci M, Jansen P, Vermeer MH, Willemze R. Klemke CD, et al. Among authors: ortonne n. Br J Dermatol. 2015 Jul;173(1):93-105. doi: 10.1111/bjd.13832. Epub 2015 Jun 23. Br J Dermatol. 2015. PMID: 25864856 Free article.

2

Cutaneous Destombes-Rosai-Dorfman disease: absence of detection of HHV-6 and HHV-8 in skin.

Ortonne N, Fillet AM, Kosuge H, Bagot M, Frances C, Wechsler J. Ortonne N, et al. J Cutan Pathol. 2002 Feb;29(2):113-8. doi: 10.1034/j.1600-0560.2002.290209.x. J Cutan Pathol. 2002. PMID: 12150132

3

Value of the CD8-CD3 ratio for the diagnosis of mycosis fungoides.

Ortonne N, Buyukbabani N, Delfau-Larue MH, Bagot M, Wechsler J. Ortonne N, et al. Mod Pathol. 2003 Sep;16(9):857-62. doi: 10.1097/01.MP.0000084112.81779.BB. Mod Pathol. 2003. PMID: 13679448

4

CD158k/KIR3DL2 is a new phenotypic marker of Sezary cells: relevance for the diagnosis and follow-up of Sezary syndrome.

Poszepczynska-Guigné E, Schiavon V, D'Incan M, Echchakir H, Musette P, Ortonne N, Boumsell L, Moretta A, Bensussan A, Bagot M. Poszepczynska-Guigné E, et al. Among authors: ortonne n. J Invest Dermatol. 2004 Mar;122(3):820-3. doi: 10.1111/j.0022-202X.2004.22326.x. J Invest Dermatol. 2004. PMID: 15086570 Free article.

5

Granuloma faciale: a clinicopathologic study of 66 patients.

Ortonne N, Wechsler J, Bagot M, Grosshans E, Cribier B. Ortonne N, et al. J Am Acad Dermatol. 2005 Dec;53(6):1002-9. doi: 10.1016/j.jaad.2005.08.021. J Am Acad Dermatol. 2005. PMID: 16310061

6

Circulating natural killer lymphocytes are potential cytotoxic effectors against autologous malignant cells in sezary syndrome patients.

Bouaziz JD, Ortonne N, Giustiniani J, Schiavon V, Huet D, Bagot M, Bensussan A. Bouaziz JD, et al. Among authors: ortonne n. J Invest Dermatol. 2005 Dec;125(6):1273-8. doi: 10.1111/j.0022-202X.2005.23914.x. J Invest Dermatol. 2005. PMID: 16354199 Free article.

7

Significance of circulating T-cell clones in Sezary syndrome.

Ortonne N, Huet D, Gaudez C, Marie-Cardine A, Schiavon V, Bagot M, Musette P, Bensussan A. Ortonne N, et al. Blood. 2006 May 15;107(10):4030-8. doi: 10.1182/blood-2005-10-4239. Epub 2006 Jan 17. Blood. 2006. PMID: 16418328 Free article.

8

[KIR3DL2: a new step for the management of patients with Sezary syndrome].

Ortonne N, Bagot M, Bensussan A. Ortonne N, et al. Med Sci (Paris). 2006 Aug-Sep;22(8-9):691-3. doi: 10.1051/medsci/20062289691. Med Sci (Paris). 2006. PMID: 16962036 Free article. French. No abstract available.

9

Identification of a novel CD160+ CD4+ T-lymphocyte subset in the skin: a possible role for CD160 in skin inflammation.

Abecassis S, Giustiniani J, Meyer N, Schiavon V, Ortonne N, Campillo JA, Bagot M, Bensussan A. Abecassis S, et al. Among authors: ortonne n. J Invest Dermatol. 2007 May;127(5):1161-6. doi: 10.1038/sj.jid.5700680. Epub 2007 Jan 11. J Invest Dermatol. 2007. PMID: 17218942 Free article.

10

Study of the reactive dendritic cells in small B-cell lymphoproliferations of the skin.

Carbonnelle A, Martin-Garcia N, Ortonne N, Laroche L, Bagot M, Molinier-Frenkel V, Wechsler J. Carbonnelle A, et al. Among authors: ortonne n. Virchows Arch. 2007 Apr;450(4):441-7. doi: 10.1007/s00428-007-0372-0. Epub 2007 Feb 15. Virchows Arch. 2007. PMID: 17377810

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

276 results

Search Page

Filters